The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry. Mass Spectrometry is a critical analytical technology used in the discovery, development, and commercialization of biopharmaceuticals.

The Netherlands Area Biotech (NLab) Discussion Group is the first CASSS discussion group located outside the US, and is intended to enable the local area community of industry, academic and regulatory professionals to meet and share ideas and experiences, thereby working together to resolve scientific challenges in the field of biopharmaceutical development and regulation.

The Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Europe.

The Japan Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Japan and Asia Pacific. The Forum strives to share information with the regulatory agencies to assist them in merging good scientific and regulatory practices.

The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

It is with great pleasure that the WCBP Scientific Organizing Committee invites you to WCBP 2023.

The Latin America Forum explores a number of critical topics focused on improving the quality in development and manufacturing of biopharmaceutical products.

Bioassays: Scientific Approaches & Regulatory Strategies is a premier bioassay symposium that presents a truly unique opportunity for attendees to interact with key industry thought leaders and discuss topics such as current perspectives, strategies and technologies used for bioassays.

Analytical Technologies Europe: Symposium on Analytical Sciences and Regulatory Trends in the Biopharmaceutical Industry provides an active forum for the discussion of recent developments, regulatory considerations, and practical applications of analytical technologies in the biopharmaceutical industry.

The CGTP Symposium demonstrates the benefits and the need to provide an ongoing dialogue and exchange of scientific and technical advances that are the basis of evolving regulatory practices for this diverse array of innovative products.

The CGTP Symposium demonstrates the benefits and the need to provide an ongoing dialogue and exchange of scientific and technical advances that are the basis of evolving regulatory practices for this diverse array of innovative products.

The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry. Mass Spectrometry is a critical analytical technology used in the discovery, development, and commercialization of biopharmaceuticals.

The goal of the CE Pharm Symposium is to provide a forum for the discussion of recent developments in CE analysis of protein, nucleotide, and small molecule pharmaceuticals. The presentations and workshops will be devoted completely to practical concerns to strengthen the use of CE within the biotechnology and pharmaceutical industries.

The Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Europe.

The Japan Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Japan and Asia Pacific. The Forum strives to share information with the regulatory agencies to assist them in merging good scientific and regulatory practices.